Catherine M. Szyman

CIK 1438538 · CEO · last filed 2026-03-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$11.52M

Companies

5

Total Filings

115

Lifetime Open-Market Net

-$46.57M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MASI CEO 8,674 $179.95 $1.56M $0 5 2026-03-16
Inari Medical, Inc. (NARI) Delisted Director 0 $79.97 $0 $533.7K 8 2025-02-19
EW CVP, Critical Care 81,287 $85.11 $6.92M -$42.15M 88 2024-09-03
OM Director 24,596 $4.49 $110.4K $0 4 2023-05-31
MDT SrVP & Pres Diabetes 36,521 $80.20 $2.93M -$4.95M 10 2014-03-21

Recent Filings · Page 6 of 12

115 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-05-11 EW Tax (F) −428 -$39.3K EDGAR
2021-05-07 EW Mixed -$235.8K EDGAR
2021-05-06 EW Grant (A) +3,975 $0 EDGAR
2021-04-22 EW Mixed -$244.4K EDGAR
2021-03-15 EW Mixed -$201.2K EDGAR
2021-02-16 EW Mixed -$223.4K EDGAR
2021-01-15 EW Mixed -$220.2K EDGAR
2020-10-29 EW Mixed -$1.04M EDGAR
2020-08-13 EW Sell (S) −2,249 -$176.0K EDGAR
2020-07-14 EW Sell (S) −2,249 -$152.2K EDGAR
Showing 5160 of 115
Page 6 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.